CUBN is a gene locus for albuminuria.


Autoria(s): Böger, C.A.; Chen, M.H.; Tin, A.; Olden, M.; Köttgen, A.; de Boer, I.H.; Fuchsberger, C.; O'Seaghdha, C.M.; Pattaro, C.; Teumer, A.; Liu, C.T.; Glazer, N.L.; Li, M.; O'Connell, J.R.; Tanaka, T.; Peralta, C.A.; Kutalik, Z.; Luan, J.; Zhao, J.H.; Hwang, S.J.; Akylbekova, E.; Kramer, H.; van der Harst, P.; Smith, A.V.; Lohman, K.; de Andrade, M.; Hayward, C.; Kollerits, B.; Tönjes, A.; Aspelund, T.; Ingelsson, E.; Eiriksdottir, G.; Launer, L.J.; Harris, T.B.; Shuldiner, A.R.; Mitchell, B.D.; Arking, D.E.; Franceschini, N.; Boerwinkle, E.; Egan, J.; Hernandez, D.; Reilly, M.; Townsend, R.R.; Lumley, T.; Siscovick, D.S.; Psaty, B.M.; Kestenbaum, B.; Haritunians, T.; Bergmann, S.; Vollenweider, P.; Waeber, G.; Mooser, V.; Waterworth, D.; Johnson, A.D.; Florez, J.C.; Meigs, J.B.; Lu, X.; Turner, S.T.; Atkinson, E.J.; Leak, T.S.; Aasarød, K.; Skorpen, F.; Syvänen, A.C.; Illig, T.; Baumert, J.; Koenig, W.; Krämer, B.K.; Devuyst, O.; Mychaleckyj, J.C.; Minelli, C.; Bakker, S.J.; Kedenko, L.; Paulweber, B.; Coassin, S.; Endlich, K.; Kroemer, H.K.; Biffar, R.; Stracke, S.; Völzke, H.; Stumvoll, M.; Mägi, R.; Campbell, H.; Vitart, V.; Hastie, N.D.; Gudnason, V.; Kardia, S.L.; Liu, Y.; Polasek, O.; Curhan, G.; Kronenberg, F.; Prokopenko, I.; Rudan, I.; Arnlöv, J.; Hallan, S.; Navis, G.; Parsa, A.; Parsa, A.; Ferrucci, L.; Coresh, J.; Shlipak, M.G.; Bull, S.B.; Paterson, N.J.; Wichmann, H.E.; Wareham, N.J.; Loos, R.J.; Rotter, J.I.; Pramstaller, P.P.; Cupples, L.A.; Beckmann, J.S.; Yang, Q.; Heid, I.M.; Rettig, R.; Dreisbach, A.W.; Bochud, M.; Fox, C.S.; Kao, W.H.; Kao W.H.
Data(s)

2011

Resumo

Identification of genetic risk factors for albuminuria may alter strategies for early prevention of CKD progression, particularly among patients with diabetes. Little is known about the influence of common genetic variants on albuminuria in both general and diabetic populations. We performed a meta-analysis of data from 63,153 individuals of European ancestry with genotype information from genome-wide association studies (CKDGen Consortium) and from a large candidate gene study (CARe Consortium) to identify susceptibility loci for the quantitative trait urinary albumin-to-creatinine ratio (UACR) and the clinical diagnosis microalbuminuria. We identified an association between a missense variant (I2984V) in the CUBN gene, which encodes cubilin, and both UACR (P = 1.1 × 10(-11)) and microalbuminuria (P = 0.001). We observed similar associations among 6981 African Americans in the CARe Consortium. The associations between this variant and both UACR and microalbuminuria were significant in individuals of European ancestry regardless of diabetes status. Finally, this variant associated with a 41% increased risk for the development of persistent microalbuminuria during 20 years of follow-up among 1304 participants with type 1 diabetes in the prospective DCCT/EDIC Study. In summary, we identified a missense CUBN variant that associates with levels of albuminuria in both the general population and in individuals with diabetes.

Identificador

https://serval.unil.ch/notice/serval:BIB_61D7BB6FF101

info:pmid:21355061

https://serval.unil.ch/resource/serval:BIB_61D7BB6FF101.P001/REF

doi:10.1681/ASN.2010060598

isiid:000288778800023

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Restricted: indefinite embargo

Copying allowed only for non-profit organizations

https://serval.unil.ch/disclaimer

Fonte

Journal of the American Society of Nephrology223555-570

Palavras-Chave #African Continental Ancestry Group/genetics; Albuminuria/genetics; European Continental Ancestry Group/genetics; Genetic Loci/genetics; Genetic Predisposition to Disease/genetics; Humans; Mutation, Missense/genetics; Receptors, Cell Surface/genetics
Tipo

info:eu-repo/semantics/article

article

Contribuinte(s)

CKDGen Consortium

Köttgen, A.

Pattaro, C.

Böger, CA.

Fuchsberger, C.

Olden, M.

Glazer, NL.

Parsa, A.

Gao, X.

Yang, Q.

Smith, AV.

O'Connell, JR.

Li, M.

Schmidt, H.

Tanaka, T.

Isaacs, A.

Ketkar, S.

Hwang, SJ.

Johnson, AD.

Dehghan, A.

Teumer, A.

Paré, G.

Aspelund, T.

Eiriksdottir, G.

Launer, LJ.

Harris, TB.

Rampersaud, E.

Mitchell, BD.

Boerwinkle, E.

Struchalin, M.

Cavalieri, M.

Singleton, A.

Giallauria, F.

Metter, J.

de Boer, I.

Haritunians, T.

Lumley, T.

Siscovick, D.

Psaty, BM.

Zillikens, MC.

Oostra, BA.

Feitosa, M.

Province, M.

Illig, T.

Klopp, N.

Meisinger, C.

Wichmann, HE.

Koenig, W.

Zgaga, L.

Zemunik, T.

Kolcic, I.

Minelli, C.

Johansson£££Åsa£££ Å.,

Igl, W.

Zaboli, G.

Wild, SH.

Wright, AF.

Campbell, H.

Ellinghaus, D.

Schreiber, S.

Aulchenko, YS.

Felix, JF.

Rivadeneira, F.

Uitterlinden, AG.

Hofman, A.

Imboden, M.

Boban, M.

Campbell, S.

Endlich, K.

Völzke, H.

Kroemer, HK.

Nauck, M.

Völker, U.

Polasek, O.

Vitart, V.

Badola, S.

Parker, AN.

Ridker, PM.

Blankenberg, S.

Gudnason, V.

Shuldiner, AR.

Coresh, J.

Schmidt, R.

Ferrucci, L.

Shlipak, MG.

van Duijn CM.,

Borecki, I.

Krämer, BK.

Rudan, I.

Gyllensten, U.

Wilson, JF.

Witteman, JC.

Pramstaller, PP.

Rettig, R.

Hastie, ND.

Chasman, DI.

Kao, WH.

Heid, IM.

Fox, CS.

Formato

application/pdf